Tumors with a PC had a larger diameter than those without (31 vs. 26 mm; P [ 0.0008). A PC was observed in 92% of clear cell, 89% of papillary, and 86% of clear cell papillary RCC cases compared to only 50% in chromophobe RCC cases (P < 0.0001). Sex, age, Furman grade, and tumor complexity did not differ among patients. A multivariate analysis showed that smaller tumor size (! 34 vs. < 34 mm, odds ratio [OR]: 3.31; P [ 0.0023) and chromophobe RCC (vs. other subtypes, OR: 12.5; P < 0.0001) predicted an absence of PC.
METHODS: Data from the National Cancer Database personal use file (NCDB) was used to evaluate trends for patients that underwent surgery to treat T1a kidney cancer. A total of 57,860 patients over the age of 29 with T1a kidney cancer were reported to the NCDB. Statistical analysis was performed to assess the association between patient's age and clinical approach. Patients were excluded if their cancer or demographics did not fit the scope of this analysis, for example, bilateral presentation or metastasis of the tumor. Patients under the age of 30 were excluded due to the small sample size (126 or less per age). Those included in the study were grouped by decade of life, except those over 80, which comprised a single group. Treatment options excluded from the study were local tumor excision, any nephrectomy (simple, subtotal, complete, partial, simple, total, radical) in continuity with the resection of other organs (i.e. colon or bladder), nephrectomy NOS, surgery NOS, and unknown if surgery performed.
RESULTS: NT is less commonly chosen in patients under the age of 80 but was the most common approach for patients 80þ. Rates of NT were 4.12%, 4.46%, 7.50%, 10.25%, 18.08% and 47.89%, respectively among the age groups. Those in the 80þ age group were significantly more likely to undergo no treatment (P<0.001). LTD had significant differences in utilization rate: 3.54%, 4.97%, 7.54%, 11.80%, 16.63% and 19.39%, respectively (P<0.001). PN was significantly less likely to be utilized in patients 80 years or older but was the most common surgical approach for all groups under 80: 73.55%, 69.50%, 63.36%, 56.39%, 44.16%, and 17.46%, respectively (P<0.001). Rates of RN were not significantly different between age groups during this time: 18.79%, 21.07%, 21.60%, 21.56%, 21.13%, 15.26%, respectively. CONCLUSIONS: When controlling for age, patients 80 years or older are more likely to receive no treatment (active surveillance) for T1a kidney tumors, and they are less likely to undergo PN compared to all other age groups. They are no less likely to undergo RN as a treatment option for T1a tumors than any other age group. These results should prompt further evaluation of treatment trends based on age, ensuring the best patient outcomes.
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Diego Aguilar Palacios*, Elvis R. Caraballo, Cleveland, OH; Hajime Tanakaa, Tokyo, Japan; Yanbo Wanga, Changchun, China, People's Republic of; Chalairat Suk-Ouichai, Bangkok, Thailand; Yunlin Ye, Guangzhou, China, People's Republic of; Lin Lin, Steven C. Campbell, Cleveland, OH INTRODUCTION AND OBJECTIVES: Loss of renal function remains a major limitation of radical nephrectomy (RN) for renal cell carcinoma (RCC). RCC patients tend to be older and have significant comorbidities, including CKD, but the timeline of functional recovery and factors predictive of degree of renal compensation have not been welldefined.
METHODS: A retrospective review was performed of all RN performed at our center from 2006-2016. 273 patients with available nuclear renal scan and imaging demonstrating non-metastatic RCC with preoperative GFR >15ml/min/1.73m2 were analyzed. GFR values were estimated by CKD-EPI preoperatively and up to 5 years after RN. Pre and postoperative volumes of the uninvolved kidney were measured by free-hand scripting from axial images at 3 mm intervals. Renal functional compensation was defined: percent change in GFR (postoperative GFR/preoperative GFR of preserved kidney). Renal parenchymal compensation was defined: percent change in parenchymal volume (postoperative volume/preoperative volume of preserved kidney). Multiple regression was used to identify predictive factors of renal compensation.
RESULTS: Median age was 67 and 67% of patients were male. Comorbidities before RN included hypertension in 70%, 28% cardiovascular disease, 26% diabetes, 55% were active/former smokers, and 37% had CKD. Median BMI was 30. Locally advanced (!T3a) tumors were found in 53% and clear cell histology in 71% of cases. Renal functional compensation was observed at 2 weeks (median 110%) and increased during the first 3 months (median 126%) after RN. Functional stability was then observed to 5 years. The median percent increase in renal parenchymal volume at 3-12 months was 10%, but in addition, the functional efficiency per unit of parenchymal volume also increased 10% (GFR units/cm3 of parenchyma was 0.21 preoperatively vs. 0.23 Vol. 201, No. 4S, Supplement, Saturday, May 4, 2019 THE JOURNAL OF UROLOGY Ò e433
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